Ann: Preliminary Final Report for period to 31 December 2018, page-9

Losing AUD$2mil cash per month ... starting 1st January with $8 mil in bank  ... almost gone now ... won't even last until AGM on 14th May...

If they sell infusions then they need to make up even more with Adapt ... BUT .. not really serious about Adapt as in no mention of TGA approval which was explained as like a cork in a bottle for Australia and SE Asia ... a major failure as in Australian TGA approval has been years in the making but not even excuses now ... quote from Sept 2018 Quarterly....  "  several accounts havesignalled their desire to wait for TGA approval rather than participate in the SAS, which furthercompounds the impact of the current approval process" ......
And while there is talk of putting more sales reps into the field it is usually just to replace those that have departed

.....TAVR success in sheep might be good but no mention of timetable to approval to sell into market ... need to have a "big-animal" series first (as in cows) still years away, even if we make it ... which we won't because we are out of money next month.

Not directly addressing these concerns means that anything WP says is not the solutions we want to hear ...